Ventus Therapeutics
Latest round
- Series C
Last raised
- Feb 2022
Total raised
- $300M
Investors
- 11
About Ventus Therapeutics
, based in Canada, focuses on developing innovative therapeutics targeting biologically validated drug targets that have been considered undruggable.Ventus Therapeutics Inc. specializes in the development of novel therapeutics aimed at challenging drug targets.Ventus Therapeutics specializes in developing differentiated therapeutics targeting biologically validated drug targets that have traditionally been seen as undruggable. Their primary products include VENT-02, a brain-penetrant NLRP3 inhibitor currently in Phase 2 trials for Parkinson’s disease, and VENT-03, a first-in-class cGAS inhibitor set to enter Phase 2 development for lupus in 2025. The ReSOLVE® platform supports these initiatives, utilizing artificial intelligence, machine learning, protein science, structural biology, and biophysics to enhance small-molecule drug discovery.Ventus Therapeutics generates revenue through collaborations and partnerships focused on drug development. The company is set to launch VENT-03 for lupus by 2025, targeting further advancements in their therapeutic offerings. Ventus aims to expand its presence within the North American market, with a focus on the United States and Canada, aligning with their ongoing commitment to address critical gaps in therapeutic options.
Who invested in Ventus Therapeutics
11 investors across 3 rounds
See all investors in Ventus Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ventus Therapeutics
Who invested in Ventus Therapeutics?
Ventus Therapeutics has 11 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ventus Therapeutics raised?
Ventus Therapeutics has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Ventus Therapeutics last raise money?
Ventus Therapeutics's most recent round on record is a Series C, in Feb 2022.
What does Ventus Therapeutics do?
, based in Canada, focuses on developing innovative therapeutics targeting biologically validated drug targets that have been considered undruggable.
Where is Ventus Therapeutics headquartered?
Ventus Therapeutics is headquartered in Montreal, Canada.
Which VCs invest in companies like Ventus Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ventus Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Ventus Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.